"Predicting Multiple Sclerosis Course and Treatment Response Through Immune Signatures and Subtype Discovery"
Researchers have identified three distinct immune signatures in the blood of people with early multiple sclerosis (MS) that are linked to specific disease trajectories and response to treatment, potentially paving the way for personalized care. By understanding individual immune system variations among patients, personalized treatment plans that are more effective and have fewer side effects could be developed. Checking a patient’s blood for a specific immune signature before starting treatment could help personalize care and improve clinical outcomes for individuals living with MS.